LRF Scientific Workshop Examines Adherence and Oral Therapies in Lymphoma and CLL
Oral medications are being increasingly used to treat patients with lymphoma and chronic lymphocytic leukemia…
News
U.S. Food and Drug Administration Approves First CAR-T Lymphoma Therapy: Axicabtagene Ciloleucel
New York, NY (October 19, 2017) – The U.S. Food and Drug Administration (FDA) announced…
Lymphoma Research Foundation Showcases Record Number of Researchers at 2017 American Society of Hematology Annual Meeting
LRF Scientific Advisory Board Members to be Joined by Current and Former Grantees at the…
U.S. Food and Drug Administration Approves Obinutuzumab for Follicular Lymphoma
New York, NY (October 31, 2017) –The U.S. Food and Drug Administration (FDA) announced it…
U.S. Food and Drug Administration Approves Brentuximab Vedotin for Cutaneous T-cell Lymphoma
New York, NY (November 9, 2017) –The U.S. Food and Drug Administration (FDA) announced it…
U.S. Food and Drug Administration Approves Acalabrutinib for Mantle Cell Lymphoma
New York, NY (October 31, 2017) –The U.S. Food and Drug Administration (FDA) announced it…
Lymphoma Research Foundation to Honor Golenbock Eiseman Assor Bell & Peskoe LLP with 2017 Hope Award
NYC Law Firm Set to Receive LRF Award at 2017 North American Educational Forum on…
Lymphoma Research Foundation Holds North American Educational Forum on Lymphoma in Brooklyn, NY
Hundreds of Lymphoma Patients and Loved Ones Set to Attend Nation’s Most Comprehensive Lymphoma Education…
Lymphoma Research Foundation Annual Gala Raises Nearly $1 Million For Research and Support Services
LRF Hosts Hundreds at “Powered by Innovation” Themed Gala at the Historic Plaza Hotel in…
Lymphoma Research Foundation Statement On the Passing of Dr. Oliver Press
The work of a physician-scientist is wholly unique: doggedly pursuing innovative research to find new…
Stay informed with news, alerts and other resources.
